Joshua A. Roth
Pfizer (United States)(US)University of Washington(US)
Publications by Year
Research Areas
Health Systems, Economic Evaluations, Quality of Life, Economic and Financial Impacts of Cancer, Biosimilars and Bioanalytical Methods, Lung Cancer Diagnosis and Treatment, Breast Cancer Treatment Studies
Most-Cited Works
- → The impact of the Oncotype Dx breast cancer assay in clinical practice: a systematic review and meta-analysis(2013)220 cited
- Prognostic value of beta1,6-branched oligosaccharides in human colorectal carcinoma.(1998)
- → Value and affordability of CAR T-cell therapy in the United States(2020)130 cited
- → Physicochemical property guidelines for modern agrochemicals(2018)119 cited
- → Cost-effectiveness of axicabtagene ciloleucel for adult patients with relapsed or refractory large B-cell lymphoma in the United States(2018)111 cited
- → A qualitative study exploring why individuals opt out of lung cancer screening(2016)96 cited
- → A formal risk-benefit framework for genomic tests: Facilitating the appropriate translation of genomics into clinical practice(2010)91 cited